A Cost-Effectiveness of Implementation Facilitation to Promote Emergency Department–Initiated Buprenorphine for Opioid Use Disorder
In the last eight years, emergency departments (EDs) have seen an influx of visits related to opioid use disorder (OUD). For the same reason, researchers have been citing EDs to be a critical setting and reachable moment for initiating OUD medications, the gold standard of care. Buprenorphine is advantageous as a low-barrier OUD treatment compared […]
Announcing the 10th Pilot Grant Cohort Advancing the Treatment of Substance Use Disorders, HCV, and HIV
CHERISH is excited to welcome a new pilot grant cohort for the 10th year. Spearheaded by CHERISH Pilot Grant Program Director Brandon Aden, the program is designed to help researchers gain familiarity with health economic evaluations, apply related methodologies to their pilot research, and build out the next stage of their careers. This year, CHERISH […]
Improving Care for Opioid Use Disorder in the Criminal-Legal System
Substance use disorders (SUD), and especially opioid use disorder (OUD), are prevalent within the criminal-legal system. Recently, there has been increased alignment of OUD care across the criminal-legal system with the patient-centered American Society of Addiction Medicine guidelines. Whether by choice or through legislation, carceral facilities are increasingly offering FDA-approved medications for OUD (MOUD), which […]
Insurance Instability for Patients with Opioid Use Disorder in the Year After Diagnosis
Access to health insurance is crucial to gaining the necessary diagnostic and therapeutic services to achieve and maintain good health. Insurance is especially necessary to access medications for opioid use disorder (MOUD) as the cost of MOUD can be a barrier to staying in treatment. If insurance coverage is disrupted, MOUD treatment may be more […]
Informing Evidence-Based Medicine for Opioid Use Disorder Using Pharmacoeconomic Studies
Since 2021, over 100,000 individuals have died each year from a drug overdose, with approximately 76 percent of those deaths involving opioids. As the US health care system contends with this growing health crisis, improved access to evidence-based medication treatment for opioid use disorder (OUD) is imperative. Pharmacoeconomics, a branch of health economics used to evaluate comparative clinical, person-centered, and economic outcomes […]
Chart of the Day: Rise in Patients with Opioid Use Disorder Leaving Hospital Prematurely
LDI Senior and Associate Fellows Ashish Thakrar, Margaret (Maggie) Lowenstein, Ryan Greysen, and M. Kit Delgado found that more people with opioid use disorder are leaving the hospital prematurely (or before medically advised), compared to marginal increases for individuals admitted for other reasons. In the study, “Trends in Before Medically Advised Discharges for Patients with Opioid Use Disorder, 2016-2020,” […]
Engage with CHERISH
Submit a Consultation Request or Contact Us to learn more about how CHERISH can support your research or policy goals.